FI843219A - Nya karboxylsyraestrar. - Google Patents

Nya karboxylsyraestrar. Download PDF

Info

Publication number
FI843219A
FI843219A FI843219A FI843219A FI843219A FI 843219 A FI843219 A FI 843219A FI 843219 A FI843219 A FI 843219A FI 843219 A FI843219 A FI 843219A FI 843219 A FI843219 A FI 843219A
Authority
FI
Finland
Prior art keywords
carboxylsyraestrar
nya
beta
distinguished
novel
Prior art date
Application number
FI843219A
Other languages
English (en)
Other versions
FI843219A0 (fi
FI80888C (fi
FI80888B (fi
Inventor
Julius Schmidlin
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI843219A0 publication Critical patent/FI843219A0/fi
Publication of FI843219A publication Critical patent/FI843219A/fi
Application granted granted Critical
Publication of FI80888B publication Critical patent/FI80888B/fi
Publication of FI80888C publication Critical patent/FI80888C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heat Sensitive Colour Forming Recording (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Fats And Perfumes (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
FI843219A 1983-08-18 1984-08-15 Foerfarande foer framstaellning av terapeutiskt verkande steroida karboxylsyraestrar. FI80888C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH451283 1983-08-18
CH451283 1983-08-18

Publications (4)

Publication Number Publication Date
FI843219A0 FI843219A0 (fi) 1984-08-15
FI843219A true FI843219A (fi) 1985-02-19
FI80888B FI80888B (fi) 1990-04-30
FI80888C FI80888C (fi) 1990-08-10

Family

ID=4277476

Family Applications (1)

Application Number Title Priority Date Filing Date
FI843219A FI80888C (fi) 1983-08-18 1984-08-15 Foerfarande foer framstaellning av terapeutiskt verkande steroida karboxylsyraestrar.

Country Status (21)

Country Link
US (1) US4607028A (fi)
EP (1) EP0135476B1 (fi)
JP (1) JPS6058999A (fi)
KR (1) KR850001725A (fi)
AT (1) ATE37186T1 (fi)
AU (1) AU3204484A (fi)
CA (1) CA1234564A (fi)
CY (1) CY1593A (fi)
DD (1) DD227966A5 (fi)
DE (1) DE3474025D1 (fi)
DK (1) DK160993C (fi)
ES (1) ES535242A0 (fi)
FI (1) FI80888C (fi)
GR (1) GR80131B (fi)
HK (1) HK42791A (fi)
HU (1) HUT34991A (fi)
IL (1) IL72702A0 (fi)
NO (1) NO160212C (fi)
PT (1) PT79106B (fi)
SG (1) SG32091G (fi)
ZA (1) ZA846406B (fi)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL78144A0 (en) * 1985-04-04 1986-07-31 Draco Ab Novel androstane-17beta-carboxylic acid esters
JPH04506066A (ja) * 1989-06-16 1992-10-22 ジ・アップジョン・カンパニー 脈管形成を抑制するためのスラミン・タイプの化合物および脈管形成抑止ステロイド類
FR2701262B1 (fr) * 1993-02-05 1995-03-24 Roussel Uclaf Nouveau procédé de préparation de stéroïdes 6 alpa, 9 alpha-difluorés et nouveaus intermédiaires.
JPH07119308A (ja) * 1993-10-27 1995-05-09 Koa:Kk 移動作業床による外壁貼りの吊り支え工法並にその装置
GB9501286D0 (en) * 1995-01-24 1995-03-15 Ciba Geigy Ag Pharmaceutical compositions and preparations thereof
US5981517A (en) * 1996-05-09 1999-11-09 Soft Drugs, Inc. Androstene derivatives
AUPP583198A0 (en) * 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
GB0015876D0 (en) * 2000-06-28 2000-08-23 Novartis Ag Organic compounds
US6750210B2 (en) * 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6777400B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6759398B2 (en) * 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6858593B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
AU7576001A (en) * 2000-08-05 2002-02-18 Glaxo Group Ltd 6.alpha., 9.alpha.-difluoro-17.alpha.-`(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
GB0029562D0 (en) * 2000-12-04 2001-01-17 Novartis Ag Organic compounds
UA77656C2 (en) * 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
EP1383786B1 (en) * 2001-04-30 2008-10-15 Glaxo Group Limited Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
GB0202216D0 (en) * 2002-01-31 2002-03-20 Glaxo Group Ltd Novel compounds
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1384372A (en) * 1971-01-20 1975-02-19 Glaxo Lab Ltd Dereivatives of 17alpha-hydroxyandrost-4-ene-17beta-carboxylic acids
GB1514476A (en) * 1974-08-30 1978-06-14 Glaxo Lab Ltd Alkyl and haloalkyl androst-4-ene and androsta-1,4-diene-17beta-carboxylates
JPS5297597A (en) * 1976-02-09 1977-08-16 Walt Disney Prod Guide device of ship
JPS5938239B2 (ja) * 1976-02-12 1984-09-14 グラクソ・ラボラトリ−ス・リミテツド 新規ステロイド化合物
CH628355A5 (de) * 1976-02-24 1982-02-26 Ciba Geigy Ag Verfahren zur herstellung neuer androstadien-17beta-carbonsaeuren und ihrer ester und salze.
CH634081A5 (en) * 1977-04-13 1983-01-14 Ciba Geigy Ag Process for the preparation of novel androstadiene-17beta-carboxylic acid esters
ZA814440B (en) * 1980-07-10 1982-10-27 Otsuka Pharma Co Ltd Soft steroids having anti-inflammatory activity

Also Published As

Publication number Publication date
EP0135476A2 (de) 1985-03-27
PT79106A (en) 1984-09-01
DD227966A5 (de) 1985-10-02
ES8601234A1 (es) 1985-11-01
HK42791A (en) 1991-06-07
PT79106B (en) 1986-11-14
EP0135476B1 (de) 1988-09-14
DE3474025D1 (en) 1988-10-20
AU3204484A (en) 1985-02-21
HUT34991A (en) 1985-05-28
SG32091G (en) 1991-06-21
NO160212B (no) 1988-12-12
DK396284D0 (da) 1984-08-17
NO843298L (no) 1985-02-19
DK160993B (da) 1991-05-13
FI843219A0 (fi) 1984-08-15
DK396284A (da) 1985-02-19
IL72702A0 (en) 1984-11-30
DK160993C (da) 1991-11-04
EP0135476A3 (en) 1985-12-18
JPH0253440B2 (fi) 1990-11-16
ES535242A0 (es) 1985-11-01
ZA846406B (en) 1985-03-27
NO160212C (no) 1989-03-22
GR80131B (en) 1984-12-19
US4607028A (en) 1986-08-19
KR850001725A (ko) 1985-04-01
CY1593A (en) 1992-04-03
FI80888C (fi) 1990-08-10
JPS6058999A (ja) 1985-04-05
ATE37186T1 (de) 1988-09-15
FI80888B (fi) 1990-04-30
CA1234564A (en) 1988-03-29

Similar Documents

Publication Publication Date Title
FI843219A (fi) Nya karboxylsyraestrar.
ES477695A1 (es) Un procedimiento para preparar derivados de deshidrociclici-minoacidos.
NO158508C (no) Analogifremgangsmaate for fremstilling av antiinflammatorisk virksomme 4-pregnenderivater.
GB1490603A (en) Glycerides with anti-inflammatory properties
FR2390433A1 (fr) Composes utiles pour la preparation de derives d'acide penicillanique
SE7607088L (sv) 5-fluor-uracilderivat.
GB2017087A (en) Process for the preparation of xanthone derivatives
PT75387B (fr) Procede de preparation de l'acide urso-desoxycholique a partir de l'acide 3-alpha 7-beta 12-alpha-trihydroxycholanique
JPS5265263A (en) Azetidinone compounds
SE7811761L (sv) 4,5,6,7-tetrahydroimidazo-(4,5-c),pyridinderivat och forfarande for deras framstellning
FI820201L (fi) Foerfarande foer framstaellning av nya n-substituerade polyglycidyl-urazolfoereningar
SE8302084L (sv) Nya bensimidazolderivat
SE8204791D0 (sv) Process for preparing alkoxy-vincaminic acid esters and alkoxy-apovincaminic acid esters
MX173415B (es) Procedimiento de preparacion de nuevos derivados de 1-estireno sulfonil-2-oxo 5-hidroxi pirrolidina y producto obtenido
GB1039880A (en) New acylaminopyrazolones and colour photographic materials containing them
FI832818A (fi) Foerfarande foer framstaellning av alfa- substituerade alkylarylketaler.
JPS5283570A (en) Thioacetals of glutarimido-beta-acetaldehydes
JPS52153965A (en) Triazolylacetic acid derivatives
JPS52118470A (en) Dithiolane derivatives
JPS5279081A (en) Preparation of novel 7-methoxycephalosporins
JPS5373508A (en) Hexanol derivative and its preparation
JPS5283869A (en) Cephalosporin compounds
JPS5283866A (en) Cephem or penam compounds
JPS52100467A (en) 8-azaprostanic acid derivatives
GB1020619A (en) Novel cinchoninic acid derivatives and a process for the manufacture thereof

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: NOVARTIS AG

MM Patent lapsed

Owner name: NOVARTIS AG